Blonanserin Tablets Market Report： the market size is projected to reach USD 0.13 billion by 2030

Blonanserin Tablets are an atypical antipsychotic medication used primarily to treat schizophrenia and related psychiatric disorders.

According to the new market research report “Blonanserin Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”, published by QYResearch, the global Blonanserin Tablets market size is projected to reach USD 0.13 billion by 2030, at a CAGR of 7.1% during the forecast period.

• Global Blonanserin Tablets MarketSize(US$ Million), 2019-2030

Source: QYResearch, "Blonanserin Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

• Global Blonanserin Tablets Top8Players Ranking and Market Share (Ranking is based on the revenue of 2023, continually updated)

Source: QYResearch, "Blonanserin Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”

According to QYResearch Top Players Research Center, the global key manufacturers of Blonanserin Tablets include Sumitomo Pharma, Recipharm, etc. In 2023, the global top three players had a share approximately 34.0% in terms of revenue.

In terms of product application, currently Adults is the largest segment, hold a share of 74.4%.

Market trend:

Rising Prevalence of Schizophrenia & Psychotic Disorders: The global burden of schizophrenia is increasing, particularly in Asia-Pacific, North America, and Europe. Growing awareness and early diagnosis drive demand for new-generation antipsychotics like Blonanserin.

Preference for Atypical Antipsychotics Over Typical Ones: Blonanserin is preferred due to fewer metabolic side effects than drugs like Olanzapine or Clozapine. Demand is increasing as it has a strong dopamine D2 receptor affinity, reducing both positive and negative schizophrenia symptoms.

Increasing Geriatric Population: The elderly population is prone to neurodegenerative disorders, leading to higher use of atypical antipsychotics.

Market challenge:

Limited Approvals Outside Asia: Blonanserin is mainly approved in Japan, South Korea, China, and India, but lacks FDA and EMA approval for U.S. and European markets. Stringent clinical trial requirements in Western countries slow down market expansion.

Generic Competition & Patent Expiry: The patent expiry of branded Blonanserin has led to a surge in generic versions, reducing profit margins. Generic alternatives make it harder for original manufacturers to sustain market dominance.

Higher Risk of Extrapyramidal Symptoms (EPS): Compared to some other atypical antipsychotics (e.g., Olanzapine, Quetiapine), Blonanserin has a higher tendency to cause movement disorders like tremors and rigidity.

Market restraints:

Higher Risk of Extrapyramidal Symptoms (EPS): Compared to other atypical antipsychotics, Blonanserin has a higher tendency to cause movement disorders (e.g., tremors, rigidity).

Lengthy and Costly Drug Approval Process: New drug applications require extensive safety and efficacy data, which slows market penetration. Regulatory agencies favor better-studied alternatives like Risperidone or Aripiprazole.

Prolactin Elevation Issues: Blonanserin may cause hormonal imbalances, leading to reduced adoption in some patient groups.

About QYResearch

QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 17 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting (data is widely cited in prospectuses, annual reports and presentations), industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.

QYResearch is a world-renowned large-scale consulting company. The industry covers various high-tech industry chain market segments, spanning the semiconductor industry chain (semiconductor equipment and parts, semiconductor materials, ICs, Foundry, packaging and testing, discrete devices, sensors, optoelectronic devices), photovoltaic industry chain (equipment, cells, modules, auxiliary material brackets, inverters, power station terminals), new energy automobile industry chain (batteries and materials, auto parts, batteries, motors, electronic control, automotive semiconductors, etc.), communication industry chain (communication system equipment, terminal equipment, electronic components, RF front-end, optical modules, 4G/5G/6G, broadband, IoT, digital economy, AI), advanced materials industry Chain (metal materials, polymer materials, ceramic materials, nano materials, etc.), machinery manufacturing industry chain (CNC machine tools, construction machinery, electrical machinery, 3C automation, industrial robots, lasers, industrial control, drones), food, beverages and pharmaceuticals, medical equipment, agriculture, etc.

Contact Us:

If you have any queries regarding this report or if you would like further information, please contact us:

QY Research Inc.

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US)  0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp